Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine
Pulmonology
Dr. Steven D. Nathan, MD
|
|
Give Review
Doctor Steven D. Nathan, MD is an expert in the field of Pulmonology. He received awards:"Regional Top Doctor" and "Super Doctor". Dr. Steven D. Nathan is a published physician. He has 90 publications published. The most current publication "Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials." Steven D. Nathan accepts Medicare payments and is listed with Medicare.gov.
Publications
- Pulmonary artery size as a predictor of outcomes in idiopathic Pulmonary fibrosis.
- Pulmonary hypertension in idiopathic Pulmonary fibrosis with mild-to-moderate restriction.
- Idiopathic Pulmonary Fibrosis in US Automated Claims: Incidence, Prevalence and Algorithm Validation.
- Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic Pulmonary fibrosis.
- Changes in fatigability following intense aerobic exercise training in patients with interstitial Lung disease.
- Cardiorespiratory Function Before and After Aerobic Exercise Training in Patients With Interstitial Lung Disease.
- Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with Chronic obstructive pulmonary disease.
- IPF clinical trial design and endpoints.
- Nebulized Medications for the Treatment of Dyspnea: A Literature Review.
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
- All-cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis: Implications for the Design and Execution of Clinical Trials.
- Pulmonary Hypertension due to Lung Disease and/or Hypoxia.
- Dysregulation of Galectin-3: Implications for Hermansky-Pudlak Syndrome Pulmonary Fibrosis.
- Identification and treatment of comorbidities in idiopathic Pulmonary fibrosis and other fibrotic lung diseases.
- The red cell distribution width as a prognostic indicator in idiopathic Pulmonary fibrosis.
- Treatment of idiopathic Pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
- Effect of aerobic exercise training on fatigue and physical activity in patients with Pulmonary arterial hypertension.
- Dynamic patient counseling: a novel concept in idiopathic Pulmonary fibrosis.
- Parameters of donor-recipient size mismatch and survival after bilateral Lung transplantation.
- Lung Size Mismatch in Bilateral Lung Transplantation Is Associated With Allograft Function and Bronchiolitis Obliterans Syndrome.
- Long-term course and prognosis of idiopathic Pulmonary fibrosis in the new millennium.
- Idiopathic non-specific interstitial Pneumonitis responsive to transplant-associated immunosuppression.
- Pulmonary complications of lung transplantation.
- Supranormal expiratory airflow after bilateral Lung transplantation is associated with improved survival.
- The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic Pulmonary fibrosis.
- Comparison of bronchiolitis obliterans syndrome to other forms of Chronic lung allograft dysfunction after lung transplantation.
- Comparison of wait times and mortality for idiopathic Pulmonary fibrosis patients listed for single or bilateral lung transplantation.
- Genomic phenotype of non-cultured Pulmonary fibroblasts in idiopathic Pulmonary fibrosis.
- Native Lung complications in single-Lung transplant recipients and the role of pneumonectomy.
- Treatment of sarcoidosis-associated Pulmonary hypertension. A two-center experience.
- Abnormal lymphangiogenesis in idiopathic Pulmonary fibrosis with insights into cellular and molecular mechanisms.
- Comorbidities of advanced Lung disease.
- Validation of a method to screen for Pulmonary hypertension in advanced idiopathic Pulmonary fibrosis.
- Idiopathic Pulmonary fibrosis and Pulmonary hypertension: connecting the dots.
- Pulmonary hypertension and Pulmonary function testing in idiopathic Pulmonary fibrosis.
- Reversal of idiopathic Pulmonary arterial hypertension and allograft pneumonectomy after single lung transplantation.
- Prevalence and outcomes of Pulmonary arterial hypertension in advanced idiopathic Pulmonary fibrosis.
- Therapeutic management of idiopathic Pulmonary fibrosis: an evidence-based approach.
- Therapeutic intervention: assessing the role of the international consensus guidelines.
- Successful lung transplantation from a donor with a saddle Pulmonary embolus.
- Lung transplantation: disease-specific considerations for referral.
- Outcomes of COPD Lung transplant recipients after Lung volume reduction surgery.
- Sarcoidosis, race, and short-term outcomes following Lung transplantation.
- Mortality from time of listing for transplantation as an indicator of candidate outcomes.
- Predicting mortality in patients with sarcoidosis awaiting Lung transplantation.
- Pulmonary embolism in idiopathic Pulmonary fibrosis transplant recipients.
- Bronchiolitis obliterans syndrome: utility of the new guidelines in single Lung transplant recipients.
- Telesupport: just reach out and touch someone.
- Outcomes for patients with sarcoidosis awaiting Lung transplantation.
- Safety of pirfenidone in patients with idiopathic Pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials.
- Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.
- Hemoglobin S-C Disease revisited: clinical study of 106 adults.
- The incidence of proximal deep vein thrombosis following total knee arthroplasty in an Asian population: a Doppler ultrasound study.
- Parenchymal trafficking of pleural mesothelial cells in idiopathic Pulmonary fibrosis.
- Use of Nd:YAG laser in endobronchial Kaposi's sarcoma.
- Spinal aspergillus abscess in a patient with bronchocentric Granulomatosis.
- Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial.
- Prediction of minimal pressure support during weaning from mechanical ventilation.
- Work of breathing after extubation.
- Ventilatory load characteristics during ventilatory muscle training.
- Pulmonary hypertension in interstitial lung disease.
- Idiopathic Pulmonary fibrosis trials: recommendations for the jury.
- Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation.
- Pulmonary hypertension in patients with Pulmonary fibrosis awaiting lung transplant.
- Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics.
- Significance of early bronchoscopic airway abnormalities after Lung transplantation.
- Utility of inhaled pentamidine prophylaxis in Lung transplant recipients.
- Transesophageal echocardiographic assessment of Pulmonary venous flow after single lung transplantation.
- Differential soluble interleukin-2R levels in bilateral bronchoalveolar lavage after single Lung transplantation.
- Obstructive flow-volume loop contours after single Lung transplantation.
- Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral Lung transplantation. A plea for multicenter immunosuppressive trials.
- Successful use of cyclosporine in a Lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome.
- Bronchiolitis obliterans in single-Lung transplant recipients.
- Aspergillus and endobronchial abnormalities in Lung transplant recipients.
- International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International So...
- Interferon gamma-1b as therapy for idiopathic Pulmonary fibrosis. An intrapatient analysis.
- The distance-saturation product predicts mortality in idiopathic Pulmonary fibrosis.
- A critical assessment of treatment options for idiopathic Pulmonary fibrosis.
- Serial development of Pulmonary hypertension in patients with idiopathic Pulmonary fibrosis.
- Prevalence and impact of coronary artery disease in idiopathic Pulmonary fibrosis.
- Pulmonary hypertension in lung diseases: survey of beliefs and practice patterns.
- Evaluation of imatinib mesylate in the treatment of Pulmonary arterial hypertension.
- Prognostic value of the 6min walk test in bronchiolitis obliterans syndrome.
- Right ventricular systolic pressure by echocardiography as a predictor of Pulmonary hypertension in idiopathic Pulmonary fibrosis.
- Categorization and impact of Pulmonary hypertension in patients with advanced COPD.
- Potential of imatinib mesylate as a novel treatment for Pulmonary fibrosis.
- Heart rate recovery after six-minute walk test predicts Pulmonary hypertension in patients with idiopathic Pulmonary fibrosis.
- The value of computed tomography scanning for the detection of coronary artery disease in patients with idiopathic Pulmonary fibrosis.
- Pulmonary hypertension secondary to interstitial lung disease.
Schools
University of The WitwatersrandFaculty of Health Sciences
Johannesburg HospLi Jewish
Li Jewish
Cedar Sinai Med Center
Procedures Preformed
- Bronchoscopy
- Ventilation Management
Conditions Treated
- Alkalosis
- Asthma
- Atelectasis
- Bronchiectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Select
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Cross Blue Shield
- Cigna HMO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care of Delaware PPO
- Coventry Health Care of Virginia HMO
- First Health (Coventry Health Care) PPO
- GEHA
- Medicare Advantage PFFS
- Choice Care PPO
- Kaiser Permanente
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medicare MCR
- Optima Health
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- Super Doctor
Education
-
Cedars-Sinai Medical Center -
North Shore-Long Island Jewish Health System -
University of the Witwatersrand
Hospital
-
Inova Fairfax Hospital
Drug Facts
| NPI NUMBER | 1891724134 | |
| NPPES Provider LastName | NATHAN | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 220423307 | |
| NPPES Provider State | VA | |
| Specialty Description | Thoracic Surgery | |
| Total Claim Count | 400.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891724134 |
| Last Name Of The Provider | NATHAN |
| First Name Of The Provider | STEVEN |
| View All |
Similar Doctors
|
Dr. Jeff Hales, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anish S. Desai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Natanyah R. Siegel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oksana Shlobin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prema Nanavaty, MD |
|
|
Dr. Shahzad Ahmad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Osman Malik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Juan C. Abril, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David Duhamel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anya C. Harry, MD
This Doctor is OpenDoctor Recommended.
|